Revised Statutes § 43-1168

Arizona Revised Statutes (ARS) § 43-1168 grants corporations an income tax credit for increasing qualified research expenses (QREs) conducted within the state, calculated using federal IRC § 41 methodology with Arizona-specific modifications.

This program, designed to incentivize local innovation, features high, tiered credit rates (up to 24%) and a crucial partial refund option for eligible small businesses, requiring mandatory compliance through both the Arizona Department of Revenue (ADOR) and the Arizona Commerce Authority (ACA).

This report provides an exhaustive analysis of ARS § 43-1168, detailing its integration with federal law, the complex calculation mechanics, the bifurcation of administrative responsibilities between the two state agencies, and the critical implications of state income modifications on the net financial benefit of the credit. Taxpayers must master these nuances to accurately model the credit’s strategic value and ensure procedural compliance.

Statutory Foundation and Context: ARS § 43-1168 Defined

ARS § 43-1168 establishes the Corporate Credit for Increased Research Activities, a foundational element of Arizona’s economic development strategy. Enacted in 1992, the statute aims to stimulate research and development activities and encourage Arizona businesses to continue investing in local innovation.

Reliance on Federal IRC § 41 and Arizona Modifications

The Arizona credit is fundamentally linked to the federal Credit for Increasing Research Activities. The allowable credit amount is determined pursuant to Internal Revenue Code (IRC) § 41, utilizing the federal standards for defining Qualified Research Expenses (QREs) and computing the incremental increase over a base amount. The calculation incorporates both the excess of QREs over the base amount defined in IRC § 41(c) and basic research payments determined under IRC § 41(e)(1)(A).

The state law includes several crucial modifications that localize the incentive:

In-State Research Requirement: Qualified research, for the purpose of the Arizona credit, includes only research conducted in this state. This scope includes research conducted at an Arizona university, provided it is paid for by the taxpayer. This mandate requires multi-state companies to precisely track and apportion QREs (wages, supplies, and contract research) solely to Arizona operations to qualify.

Decoupling from Federal Termination: The termination provisions of IRC § 41 are explicitly noted not to apply to the Arizona credit. This stability is a key policy mechanism, signaling Arizona’s long-term commitment to the R&D incentive and providing greater certainty for taxpayers engaged in multi-year capital investment planning compared to similar federal programs where sunset provisions create inherent risk.

Applicability Date: The credit applies only to expenses incurred from and after December 31, 1993.

Pass-Through Entities: If two or more taxpayers, including corporate partners in a partnership or shareholders of an S corporation, share in eligible expenses, each taxpayer is entitled to receive a proportionate share of the credit. C corporations, S corporations, partnerships, and exempt organizations subject to corporate income tax on Unrelated Business Taxable Income (UBTI) are generally eligible, though individuals must use Form 308-I.

Comprehensive Credit Calculation Mechanics

The Arizona R&D credit calculation employs a favorable tiered rate structure based on the incremental increase in Arizona-sourced QREs, requiring taxpayers to accurately determine their credit base.

Determining the Incremental Credit Base

Arizona mandates that the QREs and gross receipts used to calculate the base amount must be limited exclusively to Arizona-sourced amounts. For taxable years beginning after December 31, 2022, taxpayers may choose between two methods for computing the base amount:

The Regular Method (Incremental): This traditional method requires the computation of a fixed-base percentage. This percentage is multiplied by the average annual Arizona gross receipts for the four preceding tax years. The final credit is calculated on the excess of current-year Arizona QREs over this base amount.

The Alternative Simplified Credit (ASC): Arizona adopted the ASC, which is particularly beneficial for businesses experiencing rapid revenue growth. Under the ASC, the base amount is simplified to 50% of the average Arizona QREs incurred during the three preceding taxable years. This method often results in a lower base amount and, consequently, a higher credit, especially for firms where QREs are accelerating faster than gross receipts. The availability of the ASC, confirmed on recent ADOR tax forms, provides crucial flexibility for taxpayers optimizing their annual credit claim.

The Tiered Rate Structure

The Arizona credit is computed using a tiered rate structure that applies higher percentages to the first tranche of eligible expenses, rewarding initial investment heavily. The statutory rates are scheduled to decrease significantly beginning in 2031.

Table: ARS § 43-1168 Corporate Credit Rates: Tiered Structure and Scheduled Changes

Excess QRE Threshold	Rate (Tax Years Before 12/31/2030)	Calculation Structure	Rate (Tax Years After 12/31/2030)
Up to $2,500,000	24%	24% of that amount	20%
Amount Exceeding $2,500,000	15%	$600,000 + 15% of amount exceeding $2.5M	11%

The substantial drop in rates—from 24% to 20% and 15% to 11%—after 2030 creates a strong financial incentive for taxpayers to accelerate qualifying R&D investments into the current decade. This policy mechanism encourages immediate capital allocation by quantifying the tangible loss of tax benefit that will occur starting in 2031.

Additional University Research Credit

Arizona provides an additional, nonrefundable credit specifically for basic research payments made to universities under the jurisdiction of the Arizona Board of Regents (Arizona State University, Northern Arizona University, or the University of Arizona).

This credit is equal to 10% of the excess of the basic research payments over the taxpayer’s qualified organization base period amount. This supplementary credit is subject to stringent administrative requirements, including competitive limits. The aggregate annual cap for this additional credit is $10 million (combined corporate and individual) and requires both pre-certification from the ACA and final approval from ADOR.

Administrative Compliance and Credit Utilization

The administration of the Arizona R&D credit is split between two state agencies: the Arizona Department of Revenue (ADOR) handles the non-refundable calculation and carryforward, while the Arizona Commerce Authority (ACA) manages the highly competitive refundable portion.

Non-Refundable Credit and Carryforward

The primary credit is non-refundable, meaning it can only reduce the taxpayer’s Arizona income tax liability to zero.

• Reporting: Corporations claim the non-refundable credit using Arizona Form 308 (or Form 308-I for individuals), which must be included with the taxpayer’s income tax return.
• Credit Carryforward Rules: Any unused portion of the non-refundable credit can be carried forward, but the maximum carryforward period is dependent on the credit’s vintage:
• Credits generated for taxable years beginning before January 1, 2022, may be carried forward for 15 consecutive taxable years.
• Credits generated for taxable years beginning from and after December 31, 2021, may be carried forward for 10 consecutive taxable years.

Taxpayers must maintain detailed records tracking the year of generation for all unused credit amounts to ensure compliance with the correct expiration deadline.

The Refundable Credit Mechanism (A.R.S. § 43-1168(C))

A critical feature of the Arizona R&D credit, particularly attractive to startups and pre-profit companies, is the provision allowing for a partial refund of the excess credit. This program is established by A.R.S. § 41-1507.

• Eligibility and Calculation: The refundable option is restricted to companies employing less than 150 full-time employees. The refund amount is limited to 75% of the excess credit (the amount by which the allowable credit exceeds the tax liability for the taxable year).
• The Waiver Penalty: The remaining 25% of the excess credit is waived and cannot be carried forward. The decision to seek a refund, therefore, carries the mandatory cost of sacrificing 25% of the potential future tax benefit in exchange for immediate cash flow.
• Dual Administration and Caps: The refundable program is administered by the ACA. The taxpayer must first apply to the ACA and submit a copy of the ACA’s Certificate of Qualification to ADOR with the income tax return.
• Statewide Cap: The aggregate annual cap on the refundable credit was recently increased from $5 million to $10 million.
• Per-Taxpayer Cap: While the statute permits a 75% refund, ACA administrative guidelines impose a maximum refund of $100,000 per taxpayer in a single tax year.

The procedural requirement to obtain ACA certification before claiming the refund is strategically vital, especially since refunds are often allocated on a first-come, first-served basis. A delay in the ACA application process exposes the company to the risk that the annual statewide cap may be exhausted, thereby eliminating the opportunity for immediate liquidity. Strategic modeling must quantify the cost of waiving 25% of the credit against the benefit of receiving up to $100,000 in cash immediately.

Critical Tax Strategy: Federal Conformity and State Income Modifications

The treatment of Qualified Research Expenses (QREs) following the federal mandate under IRC § 174 to capitalize and amortize domestic R&D costs presents the most significant strategic challenge for Arizona R&D credit claimants.

The Arizona Conformity Framework

Arizona corporate taxable income (Chapter 11) generally begins with federal taxable income (FTI). To arrive at Arizona taxable income, specific statutory additions (A.R.S. § 43-1121) and subtractions (A.R.S. § 43-1122) are required to account for state-level decoupling and other adjustments.

The Absence of the QRE Subtraction Modification

Federal tax law generally requires taxpayers to reduce their deduction for R&D expenses when they claim the federal R&D credit (IRC § 280C(c)). This concept is often called preventing “double dipping.” However, the most profound impact today stems from the mandatory capitalization of R&D expenses under IRC § 174, effective for tax years beginning after December 31, 2021. This capitalization significantly increases FTI, requiring many states to offer a subtraction modification to allow the immediate deduction of QREs for state purposes.

Arizona’s tax policy creates an unavoidable tax consequence for credit claimants:

• ADOR Guidance on Expense Reduction: Arizona Department of Revenue (ADOR) guidance explicitly states that if a deduction for qualified research activities is reduced (i.e., capitalized) in the computation of federal adjusted gross income, Arizona statutes do not allow a taxpayer to take a subtraction from Arizona gross income for the amount of that expense reduction.
• The Effective Income Add-Back: Because Arizona adheres to the federal starting point but lacks the corresponding subtraction, the federally capitalized QREs effectively become taxable income at the state level. This adjustment must be reported on the corporate return using the Schedule A worksheet (line A6) of Arizona Form 120, which is used for required additions to Arizona gross income.

This tax treatment means that the act of investing in R&D and subsequently capitalizing those expenses federally creates a state-level income tax liability in Arizona. This cost must be calculated against the nominal value of the R&D credit to determine the true effective tax benefit.

Practical Application Example: Analyzing Net Credit Value

This example demonstrates the calculation of the Arizona R&D tax credit using the current tiered rates and illustrates the financial implications of the income modification.

Scenario: Innovate AZ Corporation (Tax Year 2024)

Innovate AZ is an Arizona-based C Corporation with 80 full-time employees, making it eligible for the refundable credit.

Parameter	Value	Notes
Current Year Arizona QREs	$3,500,000	All research conducted in Arizona.
Regular Method Base Amount	$750,000	Assumed, based on 5.0% fixed base percentage.
Arizona Tax Liability (Before Credit)	$200,000	Assumed.
AZ Corporate Income Tax Rate (2024)	4.9%	Current corporate rate.
Federally Capitalized QREs (IRC § 174)	$3,500,000	The full amount of QREs is capitalized federally.

Step 1: Credit Calculation (ARS § 43-1168)

The credit base (Excess QREs) is calculated as $3,500,000 – $750,000 = $2,750,000. The tiered rates are applied to this excess:

Table: Calculation of Arizona R&D Tax Credit (Pre-2030 Rates)

Component	Credit Base Allocation	Rate	Credit Amount
First Tier (Up to $2.5M)	$2,500,000	24%	$600,000
Second Tier (Excess over $2.5M)	$250,000	15%	$37,500
Total AZ R&D Tax Credit	$2,750,000	N/A	$637,500

Step 2: Income Modification Cost

Since Arizona requires the taxpayer to start with federal taxable income, the $3,500,000 in QREs that were capitalized federally must be included in Arizona taxable income (no subtraction is allowed).

• Additional State Tax Liability: $3,500,000 * 4.9% = $171,500.

Step 3: Utilization and Net Financial Benefit

1. Non-Refundable Utilization:
   • Nominal Credit Calculated: $637,500
   • Tax Liability Offset: $200,000
   • Excess Credit Remaining: $437,500
   • Credit Carried Forward (10-year period): $437,500
2. Refundable Option Analysis: Innovate AZ, with 80 employees, qualifies for the refund.
   • Potential Refund (75% of Excess): 75% * $437,500 = $328,125
   • Actual Refund Received: Limited by the per-taxpayer cap of $100,000.
   • Waived Credit: The total unused excess credit ($437,500) less the refund received ($100,000) results in a permanent waiver of $337,500 in future tax benefits.
3. Net Economic Value: The crucial factor in determining the viability of the credit is the income modification cost. The nominal credit of $637,500 is partially eroded by the $171,500 in state income tax imposed by the QRE capitalization rule. Therefore, the maximum net economic value of the credit (before utilization or carryforward decisions) is $637,500 – $171,500 = $466,000.

Final Thoughts: Strategic Compliance and Liquidity Management

ARS § 43-1168 provides one of the most substantial R&D tax incentives among US states, characterized by high rates and a commitment to long-term stability via decoupling from federal sunset provisions. However, maximizing the benefit requires navigating a complex administrative and conformity landscape.

1. Mandatory Modeling of Conformity Risk: The most significant compliance burden is Arizona’s decision not to offer an income subtraction modification for federally capitalized QREs. Taxpayers must rigorously model the increase in Arizona taxable income resulting from the IRC § 174 change (the hidden cost) to accurately determine the credit’s true net value. Simply relying on the nominal 24% rate will substantially overestimate the effective benefit.
2. Proactive Administrative Sequencing: Companies seeking the immediate cash flow from the refundable credit must prioritize the Arizona Commerce Authority (ACA) certification process. Since refunds are capped statewide and administered on a competitive basis, a delayed application to the ACA risks forfeiting access to the $10 million pool.
3. Strategic Carryforward vs. Refund Trade-off: Qualifying small businesses face a mandatory financial decision: pursue the immediate, capped refund (up to $100,000) and accept the permanent waiver of the remaining 25% of the excess credit, or maximize the long-term benefit by utilizing the full credit amount via the carryforward mechanism (10 to 15 years, depending on vintage). This choice should be driven by the company’s immediate liquidity needs versus its future profitability projections.
4. Capital Allocation Driven by Sunset Dates: The approaching statutory reduction in credit rates effective January 1, 2031, necessitates that corporations accelerate planned research expenditures into the current period to secure the current favorable rates (24% and 15%) before the scheduled decline. This policy feature generates an acute urgency for capital investment decisions.